Healthcare Executive Passes Out at Oval Office Announcement
Gordon Findlay, Healthcare Executive of Novo Nordisk, fainted Thursday during a White House event about weight loss drugs. The incident occurred at the Oval Office amid an announcement on GLP-1 medications.
Event Disruption and Medical Response
The announcement was temporarily paused as attention shifted to Findlay. President Donald Trump and Dr. Mehmet Oz reacted promptly, while the press was asked to leave the room. White House Press Secretary Karoline Leavitt confirmed the fainting and assured the public of his recovery.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly."
Context of the Announcement
President Trump revealed a deal with Eli Lilly and Novo Nordisk that would enable Americans to purchase some obesity drugs for about $150 per month. Multiple speakers addressed the audience before Findlay passed out during Eli Lilly CEO David Ricks' speech.
Aftermath and Press Conference Resumption
- Press was promptly escorted out after the incident.
- Dr. Kennedy left to provide medical assistance, as reported by White House Deputy Press Secretary Kush Desai.
- The press conference resumed at 1:29 p.m.
Author’s summary: During a White House event on obesity drug pricing, Novo Nordisk’s Gordon Findlay fainted but quickly recovered, briefly pausing the announcement led by President Trump.